跳至主要内容
临床试验/ACTRN12609001028291
ACTRN12609001028291尚未招募2 期

A single centre, prospective, randomised, comparative interventional case series investigating the effect of topical chitosan spray on haemostasis and wound healing following endoscopic dacryocystorhinostomy (endoDCR) without intubation in patients with primary acquired nasolacrimal duct obstruction.

South Australian Institute of Ophthalmology0 个研究点目标入组 26 人开始时间: 2009年11月27日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
26

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • All patients over the age of 18 years, who are able to give written informed consent.
  • All patients with primary acquired nasolacrimal duct obstruction (PANLDO) as confirmed by clinical examination and radiological investigations (dacryocystography -/+ lacrimal scintigraphy).
  • Adequate renal function (glomerular filtration calculated by Cockcroft/Gault formula or measure urine creatinine clearance > or = to 50 mL/minute)

排除标准

  • All patients with canalicular disease (obstruction/ stenosis), found either pre-operatively or at the time of surgery.
  • All patients with a history of previous nasolacrimal surgery (DCR).
  • All patients not willing to participate in the study.
  • Any patient with an allergy to shell/fish as this compound is a product of squid skeletons.

研究者

发起方
South Australian Institute of Ophthalmology

相似试验